title: Response to Coceani: Cardiac resynchronization therapy has earned its class I recommendation and continues to thrive under scrutiny.
authors.affiliation: Stavanger University Hospital, Stavanger, Norway. trout@online.no
authors.forename: Kenneth
authors.initials: K
authors.lastname: Dickstein
mesh_terms: D002304:Cardiac Pacing, Artificial / Q000592:standards* / Q000639:trends; D017147:Defibrillators, Implantable / Q000592:standards* / Q000639:trends; D019317:Evidence-Based Medicine; D005260:Female; D005544:Forecasting; D019983:Guideline Adherence; D006333:Heart Failure / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000639:trends; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D012955:Societies, Medical; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States